Patients with allergic rhinitis with or without asthma
Of the 70 patients, 6 subjects reported allergic rhinitis, 4/6 (75%)
had moderate to severe intermittent allergic rhinitis, and 2/6 (25%)
had moderate to severe persistent allergic rhinitis. 34 out of 70
experienced allergic rhinitis with asthma. With the exception of 2
patients, 32 out of 34 subjects (94.11%) reported moderate to severe
intermittent allergic rhinitis.
At T3 a significant clinical improvement, expressed in terms of nasal
and eye symptoms, was reported: T0: 7.7 ± 1.5 vs. T3: 2.4 ± 2.7
(p<0.01). In parallel, a significant decrease was found in
disease severity (T0: 8/40 (20%) vs. T3: 0/40 (100%),
p<0.01), rescue medication use (T0: 6.4 ± 2.7 vs. T3: 2.4 ±
3.2 (p<0.01)), and sleep disturbances (T0: 19/40 (47.5%) vs.
T3: 9/40 (22%), p<0.01).
A significant improvement was also recorded in school performance: T0:
9/40 (22%) vs. T3: 2/40 (5%), p<0.01.
No significant changes were reported in frequency of symptoms (≤ 4
days/week or ≤ 4 weeks : T0: 26 (65%) or 14 (35%) vs. T3: 21 (52.5%)
or 19 (47.5%); ≥ 4 days/week o ≥ 4 weeks : T0: 20 (50%) or 20
(50%) vs. T3: 28 (70%) or 12 (30%).